All News

    FDA Grants Jemperli Breakthrough Therapy Designation in dMMR/MSI-H Rectal Cancer

    December 21st 2024, 7:00pm

    Article

    Jemperli received breakthrough therapy designation by the FDA for locally advanced mismatch repair deficient/microsatellite instability-high rectal cancer.

    Darzalex Regimen May Improve MRD Responses in Multiple Myeloma

    December 21st 2024, 3:00pm

    Article

    Patients newly diagnosed with multiple myeloma who are transplant ineligible or deferred may benefit from receiving a Darzalex treatment combination.

    How to Self Advocate When Insurance Says No to Cancer Treatment Coverage

    December 20th 2024, 8:00pm

    Article

    When insurance denies coverage of cancer treatment, patients with cancer don’t need to take no for an answer, an expert explained.

    FDA Approves Braftovi Plus Erbitux and Chemo for Metastatic Colorectal Cancer Subset

    December 20th 2024, 7:03pm

    Article

    Braftovi received accelerated approval with Erbitux and mFOLFOX6 for metastatic colorectal cancer with a BRAF V600E mutation.

    Reflecting on Cancer During a Christmas Morning Run

    December 20th 2024, 6:00pm

    Article

    A reflective Christmas morning run, following a cancer diagnosis, inspires profound gratitude for life and a renewed commitment to living a meaningful life.

    NFL Star Randy Moss Undergoing Cancer Treatment, Montell Jordan Shares Update and More

    December 20th 2024, 4:00pm

    Article

    From a Pro Football Hall of Famer announcing his diagnosis to an R&B star’s latest update, here’s what’s happening in the cancer space this week.

    Zejula-Jemperli Combo Shows Promising Responses in Breast Cancer Subset

    December 20th 2024, 2:00pm

    Article

    A combination of presurgical Zejula and Jemperli showed promising treatment responses in certain patients with ER-positive, HER2-negative breast cancer.

    Enhertu May Help Preserve Quality of Life in HER2-Positive Breast Cancer

    December 19th 2024, 10:00pm

    Article

    Treatment with Enhertu showed favorable outcomes regarding health-related quality of life in patients with HER2-positive breast cancer, regardless of brain metastases.

    Targeting Multiple Pathways Improves Outcomes in Some With Metastatic Breast Cancer

    December 19th 2024, 8:00pm

    Video

    Targeting the estrogen receptor and HER2 pathways improved progression-free survival in patients with HR-positive, HER2-positive metastatic breast cancer.

    Embracing Gratitude During the Holidays

    December 19th 2024, 6:00pm

    Article

    A survivor shares tips on ways to practice gratitude the holiday season.